Everest Medicines Company

Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.
Technology: Biotechnology, Health Care, Pharmaceutical
Industry: Clinical Development
Headquarters: New York, New York, United States
Founded Date: 2017-01-01
Employees Number: 51-100
Funding Status: IPO
Investors Number: 10
Total Funding: 310000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-06-03
Last Funding Type: Series C

Visit Website
Register and Claim Ownership